Propionic acidemia: Neonatal versus selective metabolic screening

S. C. Grünert, S. Müllerleile, L. De Silva, M. Barth, M. Walter, K. Walter, T. Meissner, M. Lindner, R. Ensenauer, R. Santer, O. A. Bodamer, M. R. Baumgartner, M. Brunner-Krainz, D. Karall, C. Haase, I. Knerr, T. Marquardt, J. B. Hennermann, R. Steinfeld, S. BebloH. G. Koch, V. Konstantopoulou, S. Scholl-Bürgi, A. Van Teeffelen-Heithoff, T. Suormala, W. Sperl, J. P. Kraus, A. Superti-Furga, K. O. Schwab, J. O. Sass

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse. Study design Twenty PA patients diagnosed through NBS were compared to 35 patients diagnosed by selectivemetabolic screening (SMS) prompted by clinical findings, family history, or routine laboratory test results. Clinical and biochemical data of patients from 16metabolic centers in Germany, Austria, and Switzerland were evaluated retrospectively. Additionally, assessment of the intelligent quotient (IQ) was performed. In a second step, the number of PA patients who have died within the past 20 years was estimated based on information provided by the participating metabolic centers.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalJournal of Inherited Metabolic Disease
Volume35
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Propionic Acidemia
Newborn Infant
Austria
Switzerland
Germany

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Grünert, S. C., Müllerleile, S., De Silva, L., Barth, M., Walter, M., Walter, K., ... Sass, J. O. (2012). Propionic acidemia: Neonatal versus selective metabolic screening. Journal of Inherited Metabolic Disease, 35(1), 41-49. https://doi.org/10.1007/s10545-011-9419-0

Propionic acidemia : Neonatal versus selective metabolic screening. / Grünert, S. C.; Müllerleile, S.; De Silva, L.; Barth, M.; Walter, M.; Walter, K.; Meissner, T.; Lindner, M.; Ensenauer, R.; Santer, R.; Bodamer, O. A.; Baumgartner, M. R.; Brunner-Krainz, M.; Karall, D.; Haase, C.; Knerr, I.; Marquardt, T.; Hennermann, J. B.; Steinfeld, R.; Beblo, S.; Koch, H. G.; Konstantopoulou, V.; Scholl-Bürgi, S.; Van Teeffelen-Heithoff, A.; Suormala, T.; Sperl, W.; Kraus, J. P.; Superti-Furga, A.; Schwab, K. O.; Sass, J. O.

In: Journal of Inherited Metabolic Disease, Vol. 35, No. 1, 01.01.2012, p. 41-49.

Research output: Contribution to journalArticle

Grünert, SC, Müllerleile, S, De Silva, L, Barth, M, Walter, M, Walter, K, Meissner, T, Lindner, M, Ensenauer, R, Santer, R, Bodamer, OA, Baumgartner, MR, Brunner-Krainz, M, Karall, D, Haase, C, Knerr, I, Marquardt, T, Hennermann, JB, Steinfeld, R, Beblo, S, Koch, HG, Konstantopoulou, V, Scholl-Bürgi, S, Van Teeffelen-Heithoff, A, Suormala, T, Sperl, W, Kraus, JP, Superti-Furga, A, Schwab, KO & Sass, JO 2012, 'Propionic acidemia: Neonatal versus selective metabolic screening', Journal of Inherited Metabolic Disease, vol. 35, no. 1, pp. 41-49. https://doi.org/10.1007/s10545-011-9419-0
Grünert SC, Müllerleile S, De Silva L, Barth M, Walter M, Walter K et al. Propionic acidemia: Neonatal versus selective metabolic screening. Journal of Inherited Metabolic Disease. 2012 Jan 1;35(1):41-49. https://doi.org/10.1007/s10545-011-9419-0
Grünert, S. C. ; Müllerleile, S. ; De Silva, L. ; Barth, M. ; Walter, M. ; Walter, K. ; Meissner, T. ; Lindner, M. ; Ensenauer, R. ; Santer, R. ; Bodamer, O. A. ; Baumgartner, M. R. ; Brunner-Krainz, M. ; Karall, D. ; Haase, C. ; Knerr, I. ; Marquardt, T. ; Hennermann, J. B. ; Steinfeld, R. ; Beblo, S. ; Koch, H. G. ; Konstantopoulou, V. ; Scholl-Bürgi, S. ; Van Teeffelen-Heithoff, A. ; Suormala, T. ; Sperl, W. ; Kraus, J. P. ; Superti-Furga, A. ; Schwab, K. O. ; Sass, J. O. / Propionic acidemia : Neonatal versus selective metabolic screening. In: Journal of Inherited Metabolic Disease. 2012 ; Vol. 35, No. 1. pp. 41-49.
@article{add3230254a94555ba84de2c53923863,
title = "Propionic acidemia: Neonatal versus selective metabolic screening",
abstract = "Background Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse. Study design Twenty PA patients diagnosed through NBS were compared to 35 patients diagnosed by selectivemetabolic screening (SMS) prompted by clinical findings, family history, or routine laboratory test results. Clinical and biochemical data of patients from 16metabolic centers in Germany, Austria, and Switzerland were evaluated retrospectively. Additionally, assessment of the intelligent quotient (IQ) was performed. In a second step, the number of PA patients who have died within the past 20 years was estimated based on information provided by the participating metabolic centers.",
author = "Gr{\"u}nert, {S. C.} and S. M{\"u}llerleile and {De Silva}, L. and M. Barth and M. Walter and K. Walter and T. Meissner and M. Lindner and R. Ensenauer and R. Santer and Bodamer, {O. A.} and Baumgartner, {M. R.} and M. Brunner-Krainz and D. Karall and C. Haase and I. Knerr and T. Marquardt and Hennermann, {J. B.} and R. Steinfeld and S. Beblo and Koch, {H. G.} and V. Konstantopoulou and S. Scholl-B{\"u}rgi and {Van Teeffelen-Heithoff}, A. and T. Suormala and W. Sperl and Kraus, {J. P.} and A. Superti-Furga and Schwab, {K. O.} and Sass, {J. O.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s10545-011-9419-0",
language = "English",
volume = "35",
pages = "41--49",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Propionic acidemia

T2 - Neonatal versus selective metabolic screening

AU - Grünert, S. C.

AU - Müllerleile, S.

AU - De Silva, L.

AU - Barth, M.

AU - Walter, M.

AU - Walter, K.

AU - Meissner, T.

AU - Lindner, M.

AU - Ensenauer, R.

AU - Santer, R.

AU - Bodamer, O. A.

AU - Baumgartner, M. R.

AU - Brunner-Krainz, M.

AU - Karall, D.

AU - Haase, C.

AU - Knerr, I.

AU - Marquardt, T.

AU - Hennermann, J. B.

AU - Steinfeld, R.

AU - Beblo, S.

AU - Koch, H. G.

AU - Konstantopoulou, V.

AU - Scholl-Bürgi, S.

AU - Van Teeffelen-Heithoff, A.

AU - Suormala, T.

AU - Sperl, W.

AU - Kraus, J. P.

AU - Superti-Furga, A.

AU - Schwab, K. O.

AU - Sass, J. O.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse. Study design Twenty PA patients diagnosed through NBS were compared to 35 patients diagnosed by selectivemetabolic screening (SMS) prompted by clinical findings, family history, or routine laboratory test results. Clinical and biochemical data of patients from 16metabolic centers in Germany, Austria, and Switzerland were evaluated retrospectively. Additionally, assessment of the intelligent quotient (IQ) was performed. In a second step, the number of PA patients who have died within the past 20 years was estimated based on information provided by the participating metabolic centers.

AB - Background Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse. Study design Twenty PA patients diagnosed through NBS were compared to 35 patients diagnosed by selectivemetabolic screening (SMS) prompted by clinical findings, family history, or routine laboratory test results. Clinical and biochemical data of patients from 16metabolic centers in Germany, Austria, and Switzerland were evaluated retrospectively. Additionally, assessment of the intelligent quotient (IQ) was performed. In a second step, the number of PA patients who have died within the past 20 years was estimated based on information provided by the participating metabolic centers.

UR - http://www.scopus.com/inward/record.url?scp=84863331433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863331433&partnerID=8YFLogxK

U2 - 10.1007/s10545-011-9419-0

DO - 10.1007/s10545-011-9419-0

M3 - Article

C2 - 22134541

AN - SCOPUS:84863331433

VL - 35

SP - 41

EP - 49

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 1

ER -